Breast biopsy techniques

🔬 Indications for Biopsy

• Palpable Mass: Any new, dominant, firm, or persistent solid mass.
• Nipple/Areolar Changes:
  • Unilateral, spontaneous, bloody, or serosanguinous discharge.
  • Persistent eczema/ulceration (suspect Paget's disease).
• Skin Changes: Peau d'orange, dimpling, retraction, erythema.
• Imaging Findings: Based on Breast Imaging Reporting and Data System (BI-RADS).

⭐ A new palpable mass in a woman >30 years old, or any solid mass in a postmenopausal woman, requires tissue diagnosis, regardless of mammogram findings.

🔬 Radiology - The Biopsy Toolkit

The goal is histopathologic diagnosis of suspicious breast lesions. The choice of technique depends on the lesion type and imaging visibility.

• Fine-Needle Aspiration (FNA):

  • Uses a small (22-27 gauge) needle for cytology (cells).
  • Main use: Draining simple cysts, sampling axillary nodes.
  • ⚠️ Cannot distinguish invasive from in-situ disease.

• Core Needle Biopsy (CNB):

  • Gold standard for initial diagnosis.
  • Uses a larger (14-gauge) needle for histology (tissue architecture).
  • Vacuum-assisted biopsy (VAB) is a type of CNB that obtains larger, contiguous samples, ideal for calcifications.

• Surgical (Excisional) Biopsy:

  • Removes the entire lesion.
  • Used when percutaneous biopsy is discordant, non-diagnostic, or for specific high-risk lesions.

⭐ Always correlate biopsy results with imaging findings. A "benign" pathology report for a highly suspicious (BI-RADS 5) lesion is considered discordant and requires surgical excision.

🔬 Management - Choosing the Right Tool

• Fine Needle Aspiration (FNA):
  • Best for simple cysts (diagnostic & therapeutic).
  • Provides cytology only; cannot distinguish DCIS from invasive cancer.
• Core Needle Biopsy (CNB):
  • Initial standard for solid masses & suspicious calcifications.
  • Provides histology (tissue architecture).
  • Guided by US (masses), stereotaxis (calcifications), or MRI.
• Surgical (Excisional) Biopsy:
  • Used when CNB is inconclusive, discordant with imaging, or for high-risk lesions (e.g., ADH) due to upgrade risk.

⭐ Core needle biopsy (CNB) is preferred over Fine Needle Aspiration (FNA) for solid masses because it provides tissue architecture, allowing differentiation between in-situ and invasive carcinoma.

🩹 Complications - Post-Poke Problems

• Hematoma/Bleeding: Most common; manage with direct pressure.
• Infection (Cellulitis): Rare; presents with erythema, warmth, pain.
• Pain & Bruising: Expected, self-limited.
• Pneumothorax: ⚠️ Very rare; risk with deep lesions near the chest wall.
• Vasovagal Syncope: Fainting during the procedure.
• False Negative: Risk varies by technique (↑FNA, ↓Excisional).

⭐ Post-biopsy hematomas can obscure or mimic malignancy on follow-up mammograms, complicating interpretation.

⚡ Biggest Takeaways

• Fine Needle Aspiration (FNA) provides cytology only; it cannot differentiate in-situ from invasive disease.
• Core Needle Biopsy (CNB) is the initial standard of care for most breast lesions, providing crucial histology.
• Use ultrasound-guided CNB for suspicious masses and stereotactic CNB for non-palpable microcalcifications.
• Excisional biopsy removes the entire lesion; indicated for discordant CNB results or certain high-risk lesions.
• Sentinel Lymph Node Biopsy (SLNB) is a staging procedure for invasive cancer, not a primary diagnostic biopsy.